Advanced Immunobiology Traning Program for Surgeons
外科医生高级免疫生物学培训计划
基本信息
- 批准号:10598547
- 负责人:
- 金额:$ 25.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract
Immunobiology has become increasingly relevant to surgical practice, influencing diverse disciplines including
oncology, inflammatory bowel disease, transplantation, trauma and critical care. Although the importance of
immune manipulation has become an evident adjunct to surgical practice, surgical training neither includes
advanced immunology nor prepares surgeon-scientists to participate in immune-related research. This training
grant application seeks funding for the formation of the Advanced Immunobiology Training Program (AITP) at
Duke University to create surgeon-scientists capable of participating in and leading surgically relevant areas of
immunobiological research. The training program will combine the substantial academic rigor of the Duke
University School of Medicine with the Duke Department of Surgery's longstanding and highly successful
commitment to training the next generation of surgical researchers. The program will be co-directed by an
academic surgeon and a basic sciences researcher, each with expertise in immunology. Supplemented by
mentors with expertise in basic, translational, and clinical research, this multidisciplinary team is uniquely
qualified to merge basic and applied immunobiology with evolving surgical practice. Program participants will
consist of postdoctoral trainees who have completed medical school and initiated surgical residency. At least
six individuals will be trained during the proposed funding period. Based on individual development plans, each
trainee will choose to participate in either a two- or three-year training program, with opportunities to complete
a Master of Health Sciences degree in Clinical Research, or pursue a PhD in Immunology. Trainees will select
a primary mentor from a highly experienced and diverse group of 16 basic, translational or clinical
immunobiological researchers. Guided by their mentor, they will follow a structured didactic curriculum that will
transition to a mentored research experience. A robust research infrastructure and substantial departmental
resources will support the students, facilitating their conduct and publication of original investigations with
complete protection from clinical service. Specific instruction in immunological investigation will be provided, as
will mentorship in scientific writing, publication, ethics and clinical time management.
项目摘要/摘要
免疫生物学已与外科实践越来越相关,影响了包括
肿瘤学,炎症性肠病,移植,创伤和重症监护。虽然重要性
免疫操纵已成为手术练习的明显辅助手术,手术训练都不包括
先进的免疫学也不准备外科医生科学家参加与免疫相关的研究。这个培训
Grant申请寻求资金用于成立高级免疫生物学培训计划(AITP)
杜克大学创建能够参与和领导外科手术相关领域的外科医生科学家
免疫生物学研究。培训计划将结合公爵的严格严格
杜克大学外科部长的大学医学院长期以来的长期成功
致力于培训下一代外科研究人员。该程序将由
学术外科医生和基础科学研究人员,每个研究人员都有免疫学专业知识。补充
具有基础,转化和临床研究专业知识的导师,这个多学科团队是独特的
有资格将基本和应用的免疫生物学与不断发展的手术实践合并。计划参与者会
由已完成医学院并开始手术居住的博士后学员组成。至少
在拟议的资助期间,将对六个人进行培训。根据个人发展计划,每个计划
受训者将选择参加为期两年或三年的培训计划,并有机会完成
临床研究的健康科学硕士学位,或攻读免疫学博士学位。学员将选择
来自经验丰富且多样化的16个基本,翻译或临床的主要导师
免疫生物学研究人员。在他们的导师的指导下,他们将遵循结构化的教学课程
过渡到指导的研究经验。强大的研究基础设施和实质性的部门
资源将支持学生,促进他们的行为和发表原始调查的行为
完全保护临床服务。将提供免疫学调查中的具体指导,如
将指导科学写作,出版,道德和临床时间管理。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Gene Therapy: Will the Promise of Optimizing Lung Allografts Become Reality?
- DOI:10.3389/fimmu.2022.931524
- 发表时间:2022
- 期刊:
- 影响因子:7.3
- 作者:
- 通讯作者:
Complement-targeting therapeutics for ischemia-reperfusion injury in transplantation and the potential for ex vivo delivery.
- DOI:10.3389/fimmu.2022.1000172
- 发表时间:2022
- 期刊:
- 影响因子:7.3
- 作者:
- 通讯作者:
Harnessing the B Cell Response in Kidney Transplantation - Current State and Future Directions.
- DOI:10.3389/fimmu.2022.903068
- 发表时间:2022
- 期刊:
- 影响因子:7.3
- 作者:
- 通讯作者:
Complement-targeted therapies in kidney transplantation-insights from preclinical studies.
- DOI:10.3389/fimmu.2022.984090
- 发表时间:2022
- 期刊:
- 影响因子:7.3
- 作者:Anwar, Imran J.;DeLaura, Isabel;Ladowski, Joseph;Gao, Qimeng;Knechtle, Stuart J.;Kwun, Jean
- 通讯作者:Kwun, Jean
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Allan D. Kirk其他文献
Assessing Quality of Real-World Data Supplied by an Automated Surgical Data Pipeline
- DOI:
10.1016/j.jamcollsurg.2019.08.203 - 发表时间:
2019-10-01 - 期刊:
- 影响因子:
- 作者:
Kristin Corey;Joshua Helmkamp;Allan D. Kirk;Suresh Balu;David Thompson;Leila Mureebe;Joshua Watson;Keith Marsolo;Lesley Curtis;Mark Sendak - 通讯作者:
Mark Sendak
Toll-Like Receptor Signaling as a Prognostic Tool in Trauma Patients
- DOI:
10.1016/j.jamcollsurg.2016.06.346 - 发表时间:
2016-10-01 - 期刊:
- 影响因子:
- 作者:
Marcus D. Darrabie;Jaewoo Lee;Jennifer Cheeseman;Alexander T. Limkakeng;Steven N. Vaslef;Bruce A. Sullenger;Allan D. Kirk - 通讯作者:
Allan D. Kirk
A novel calcineurin inhibitor– and sirolimus-free anti-LFA-1-based therapy enhances allogeneic islet survival and function in nonhuman primates
- DOI:
10.1016/j.jamcollsurg.2009.06.133 - 发表时间:
2009-09-01 - 期刊:
- 影响因子:
- 作者:
Idelberto R. Badell;Alexandra P. Turner;Jose A. Cano;Jose G. Avila;Brandi E. Johnson;Frank V. Leopardi;Sarah G. Swygert;Elizabeth A. Strobert;Allan D. Kirk;Christian P. Larsen - 通讯作者:
Christian P. Larsen
Immunosuppression without immunosuppression? How to be a tolerant individual in a dangerous world
没有免疫抑制的免疫抑制?
- DOI:
10.1034/j.1399-3062.1999.10107.x - 发表时间:
1999 - 期刊:
- 影响因子:2.6
- 作者:
Allan D. Kirk - 通讯作者:
Allan D. Kirk
Allan D. Kirk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Allan D. Kirk', 18)}}的其他基金
Advanced Immunobiology Traning Program for Surgeons
外科医生高级免疫生物学培训计划
- 批准号:
10396460 - 财政年份:2019
- 资助金额:
$ 25.42万 - 项目类别:
Depletion, Repopulation and Tolerance in Non-Sensitied Recipients
非敏感受体的消耗、再生和耐受性
- 批准号:
9980790 - 财政年份:2017
- 资助金额:
$ 25.42万 - 项目类别:
Depletion, Repopulation and Tolerance in Non-Sensitied Recipients
非敏感受体的消耗、再生和耐受性
- 批准号:
10214495 - 财政年份:2017
- 资助金额:
$ 25.42万 - 项目类别:
Depletion, Repopulation and Tolerance in Non-Sensitied Recipients
非敏感受体的消耗、再生和耐受性
- 批准号:
10649945 - 财政年份:2017
- 资助金额:
$ 25.42万 - 项目类别:
Cell Adhesion and Trafficking as a Therapeutic Target in Allotransplantation
细胞粘附和运输作为同种异体移植的治疗靶点
- 批准号:
8705985 - 财政年份:2014
- 资助金额:
$ 25.42万 - 项目类别:
T Cell Maturation and the Nexus of Viral- and Allo-Immunity
T 细胞成熟以及病毒免疫和同种异体免疫的关系
- 批准号:
8371823 - 财政年份:2012
- 资助金额:
$ 25.42万 - 项目类别:
T Cell Maturation and the Nexus of Viral- and Allo-Immunity
T 细胞成熟以及病毒免疫和同种异体免疫的关系
- 批准号:
8463978 - 财政年份:2012
- 资助金额:
$ 25.42万 - 项目类别:
T Cell Maturation and the Nexus of Viral- and Allo-Immunity
T 细胞成熟以及病毒免疫和同种异体免疫的关系
- 批准号:
8607811 - 财政年份:2012
- 资助金额:
$ 25.42万 - 项目类别:
ADJUVANT THERAPIES IMPROVING ANTI-REJECTION EFFECTS OF COSTIMULATION BLOCKADE
辅助疗法改善共同刺激封锁的抗排斥效果
- 批准号:
8357527 - 财政年份:2011
- 资助金额:
$ 25.42万 - 项目类别:
相似海外基金
Remodeling host immunity in oral cancer with personalized RNA nanoparticle vaccines
利用个性化 RNA 纳米颗粒疫苗重塑口腔癌宿主免疫力
- 批准号:
10427461 - 财政年份:2022
- 资助金额:
$ 25.42万 - 项目类别:
Remodeling host immunity in oral cancer with personalized RNA nanoparticle vaccines
利用个性化 RNA 纳米颗粒疫苗重塑口腔癌宿主免疫力
- 批准号:
10633111 - 财政年份:2022
- 资助金额:
$ 25.42万 - 项目类别:
Defining the relationship between host-microbiome interactions and rejection after intestinal transplantation
定义宿主-微生物组相互作用与肠移植后排斥反应之间的关系
- 批准号:
10609513 - 财政年份:2021
- 资助金额:
$ 25.42万 - 项目类别:
Defining the relationship between host-microbiome interactions and rejection after intestinal transplantation
定义宿主-微生物组相互作用与肠移植后排斥反应之间的关系
- 批准号:
10301316 - 财政年份:2021
- 资助金额:
$ 25.42万 - 项目类别:
Defining the relationship between host-microbiome interactions and rejection after intestinal transplantation
定义宿主-微生物组相互作用与肠移植后排斥反应之间的关系
- 批准号:
10406372 - 财政年份:2021
- 资助金额:
$ 25.42万 - 项目类别: